S. Cox Carrie's most recent trade in Organon & Co. was a trade of 65,400 Common Stock done at an average price of $7.7 . Disclosure was reported to the exchange on Nov. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organon & Co. | Carrie S. Cox | Director, Executive Chair | Purchase of securities on an exchange or from another person at price $ 7.67 per share. | 12 Nov 2025 | 65,400 | 77,869 | - | 7.7 | 501,755 | Common Stock |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 23,904 | 74,029 | - | - | Phantom Stock | |
| Organon & Co. | Carrie S. Cox | Director | Purchase of securities on an exchange or from another person at price $ 8.07 per share. | 14 May 2025 | 12,469 | 12,469 | - | 8.1 | 100,591 | Common Stock |
| Solventum | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 5,148 | 0 | - | - | Restricted Stock Units | |
| Solventum | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2025 | 5,148 | 5,148 | - | 0 | Common Stock | |
| Solventum | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 4,916 | 4,916 | - | - | Restricted Stock Units | |
| Texas Instruments | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 2,551 | 2,551 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 614 | 37,101 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,600 | 15,629 (0%) | 0% | 0 | Common Stock | |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,638 | 47,059 | - | - | Phantom Stock | |
| Solventum | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 6,336 | 11,484 | - | - | Restricted Stock Units | |
| Solventum | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 5,148 | 5,148 | - | - | Restricted Stock Units | |
| Texas Instruments | S. Carrie Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 3,066 | 3,066 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | S. Cox Carrie | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2024 | 686 | 36,487 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | S. Carrie Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 248,000 | 248,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Carrie Cox S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 178,000 | 390,881 (0%) | 0% | 0 | Common Stock | |
| Texas Instruments | Carrie S. Cox | Director | Sale of securities on an exchange or to another person at price $ 180.04 per share. | 31 Jul 2023 | 16,055 | 35,801 (0%) | 0% | 180.0 | 2,890,542 | Common Stock |
| Texas Instruments | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.93 per share. | 31 Jul 2023 | 9,990 | 45,791 (0%) | 0% | 52.9 | 528,771 | Common Stock |
| Texas Instruments | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 9,990 | 0 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2023 | 6,065 | 0 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Carrie S. Cox | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.26 per share. | 31 Jul 2023 | 6,065 | 51,856 (0%) | 0% | 79.3 | 480,712 | Common Stock |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 10,086 | 35,232 | - | - | Phantom Stock | |
| Texas Instruments | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 2,159 | 2,159 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 574 | 35,801 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 107,500 | 107,500 | - | - | Stock Option (Right to Buy) | |
| Cardinal Health | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2022 | 2,308 | 41,631 (0%) | 0% | 0 | Common Shares | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 13 Jun 2022 | 130,000 | 212,881 (0%) | 0% | 1.2 | 149,799 | Common Stock |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 5,640 | 24,187 | - | - | Phantom Stock | |
| Texas Instruments | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 2,512 | 2,512 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 572 | 35,227 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 03 Dec 2021 | 17,200 | 82,881 (0%) | 0% | 2.9 | 50,664 | Common Stock |
| Cardinal Health | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,709 | 39,323 (0%) | 0% | 0 | Common Shares | |
| Organon & Co. | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 18,079 | 18,079 | - | - | Phantom Stock | |
| Selecta Biosciences Inc | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Texas Instruments | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 2,457 | 2,457 | - | - | NQ Stock Option (Right to Buy) | |
| Texas Instruments | Carrie S. Cox | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 590 | 34,655 (0%) | 0% | 0 | Common Stock |